Effects of dietary Pb on accumulation, histopathology, and digestive enzyme activities in the digestive system of tilapia (Oreochromis niloticus).
With the increasing occurrence of dietary lead (Pb) contamination in aquatic environment, threat of the dietary Pb toxicity to aquatic organisms attracted more attention. In this study, after being exposed to dietary Pb at concentrations of 0, 100, 400, and 800-microg/g dry weight for 60 days, the groups of tilapia (Oreochromis niloticus) were sacrificed and sampled to analyze the effects of dietary Pb on accumulation, histopathology, and digestive enzyme activities in tissues of the digestive system. The results showed that the Pb accumulation in tissues increased with the dietary Pb concentrations. Moreover, Pb accumulated in sampled tissues in the following order: intestine > stomach > liver. By observation of liver histological sections in optical microscope, lesions could be detected in the Pb-contaminated groups. It was also demonstrated that the inhibitory effect of dietary Pb on digestive enzyme activities was dietary Pb concentration dependent. Different degrees of inhibition of enzyme activities were exhibited in sampled tissues. It was indicated that digestive enzyme activities in the digestive system might be considered as the potential biomarkers of dietary Pb contamination in tilapia.
Dai
Wei
W
Key Laboratory for Molecular Animal Nutrition of Ministry of Education, Feed Science Institute, Zhejiang University, Hangzhou, 310029, People's Republic of China.
Du
Huahua
H
Fu
Linglin
L
Jin
Chengguan
C
Xu
Zirong
Z
Liu
Huitao
H
D000681:Amylases / Q000037:antagonists & inhibitors / Q000378:metabolism; D000818:Animals; D004032:Diet; D004064:Digestive System / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology*; D005753:Gastric Mucosa / Q000378:metabolism; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000187:drug effects / Q000201:enzymology; D007854:Lead / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000633:toxicity; D008049:Lipase / Q000037:antagonists & inhibitors / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D008297:Male; D011897:Random Allocation; D013270:Stomach / Q000187:drug effects / Q000201:enzymology; D017210:Tilapia / Q000378:metabolism*; D014357:Trypsin / Q000378:metabolism; D014361:Trypsin Inhibitors
D014361:Trypsin Inhibitors; D007854:Lead; D008049:Lipase; D000681:Amylases; D014357:Trypsin